Search - tctmd.com

Displaying 101 - 120 of 1127

Sort: Relevancy | Date

News Industry News

CellProthera announces positive Phase I/IIb data for ProtheraCytes® cell therapy in acute myocardial infarction

May 29, 2024

News Conference News EuroPCR 2024

Stepwise DAPT De-escalation Shows Promise in DCB-Only PCI for ACS

Yael L. Maxwell

May 15, 2024

News Conference News SCAI 2024

Radial PCI Benefits Seen in Real-world Analysis, Mirroring RCTs

L.A. McKeown

May 10, 2024

News Daily News

TAVI Outcomes Linked to LV Recovery in Patients With Severe Dysfunction

Michael O'Riordan

May 06, 2024

News Daily News

Again and Again, Trials Back Short DAPT Post-PCI in ACS: Practice Slow to Shift

Yael L. Maxwell

May 03, 2024

News Conference News ACC 2024

Triglyceride-Lowering Therapies Provide Favorable Outcomes in Early Testing

Michael O'Riordan

April 12, 2024

Presentation Fellows 2024

The Role of Coronary Revascularization for Stable Ischemic Heart Disease

Presenter: Ajay J. Kirtane

April 12, 2024

News Conference News EHRA 2024

Preventive VT Ablation Before ICD Helps High-risk Ischemic Cardiomyopathy Patients

Todd Neale

April 10, 2024

$Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC$

News Conference News ACC 2024

Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC

Michael O'Riordan

April 08, 2024

News Conference News ACC 2024

ULTIMATE-DAPT: Another Boost for Solo Ticagrelor 1 Month After ACS PCI

Yael L. Maxwell

April 07, 2024

Presentation ACC 2024

ApoA-I Event ReducinG in Ischemic Syndromes II (AEGIS-II) Trial

Presenter: C. Michael Gibson

April 06, 2024

News Daily News

When Moving From DAPT to Monotherapy After PCI, the P2Y12 Inhibitor Matters

Yael L. Maxwell

March 21, 2024

News Daily News

Even After Multivessel or LM PCI, Routine Stress Testing Adds Nothing

Yael L. Maxwell

March 01, 2024

News Daily News

More Complications in Pregnancy Equals Higher Risk of ASCVD Mortality

Caitlin E. Cox

February 28, 2024

News Daily News

High-Protein Diets Linked to Amino Acid Activation of ASCVD Pathway

L.A. McKeown

February 21, 2024

News Daily News

Low Bleeding Profile With Asundexian Seen in Pooled Analysis

L.A. McKeown

February 13, 2024

News Daily News

Alcohol’s Impact on IHD Mortality Hinges on Socioeconomic Status

Caitlin E. Cox

February 07, 2024

Presentation CTO 2024

Ischemic Cardiomyopathy: When and How Should I Revascularize?

Presenter: Jason Wollmuth

February 02, 2024

News Daily News

No Benefit to P2Y12 Inhibitor Pretreatment in STEMI, Bern-PCI Data Confirm

Yael L. Maxwell

January 10, 2024

News Daily News

TLR Rates Rise Steadily After Left Main PCI, but Deaths Stay Stable

Michael O'Riordan

January 09, 2024

Advertisement

CellProthera announces positive Phase I/IIb data for ProtheraCytes® cell therapy in acute myocardial infarction

Stepwise DAPT De-escalation Shows Promise in DCB-Only PCI for ACS

Radial PCI Benefits Seen in Real-world Analysis, Mirroring RCTs

TAVI Outcomes Linked to LV Recovery in Patients With Severe Dysfunction

Again and Again, Trials Back Short DAPT Post-PCI in ACS: Practice Slow to Shift

Triglyceride-Lowering Therapies Provide Favorable Outcomes in Early Testing

The Role of Coronary Revascularization for Stable Ischemic Heart Disease

Preventive VT Ablation Before ICD Helps High-risk Ischemic Cardiomyopathy Patients

Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC

ULTIMATE-DAPT: Another Boost for Solo Ticagrelor 1 Month After ACS PCI

ApoA-I Event ReducinG in Ischemic Syndromes II (AEGIS-II) Trial

When Moving From DAPT to Monotherapy After PCI, the P2Y12 Inhibitor Matters

Even After Multivessel or LM PCI, Routine Stress Testing Adds Nothing

More Complications in Pregnancy Equals Higher Risk of ASCVD Mortality

High-Protein Diets Linked to Amino Acid Activation of ASCVD Pathway

Low Bleeding Profile With Asundexian Seen in Pooled Analysis

Alcohol’s Impact on IHD Mortality Hinges on Socioeconomic Status

Ischemic Cardiomyopathy: When and How Should I Revascularize?

No Benefit to P2Y12 Inhibitor Pretreatment in STEMI, Bern-PCI Data Confirm

TLR Rates Rise Steadily After Left Main PCI, but Deaths Stay Stable

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content